← Back to Clinical Trials
Recruiting NCT06736782

NCT06736782 Holistic Self-Empowerment Care Intervention for Optimized Independent Living and Quality of Life: A Study Protocol

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06736782
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Long-Term Care
Study Type INTERVENTIONAL
Enrollment 207 participants
Start Date 2024-07-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Self-Empowerment Care Intervention GroupControl Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 207 participants in total. It began in 2024-07-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This protocol describes a pilot study evaluating the effectiveness of the Self-Empowerment Care Model in promoting independence and quality of life among frail older adults in Hong Kong. Rooted in Nordic re-enablement principles and refined in Japan, the intervention adopts a holistic approach that focuses on hydration, exercise, diet, and defecation care. This 12-week intervention will be tested across three care settings-residential, day care, and home care. The study uses a quasi-experimental design involving 60 participants, aiming to compare outcomes of the intervention group with a control group receiving standard care. The study also assesses its impact on caregivers' burden and job satisfaction.

Eligibility Criteria

Inclusion Criteria: * Age 65 years or older * Functional decline * Potential to benefit from reablement. Exclusion Criteria: * Severe cognitive impairment, those with mild impairment will be considered. * Severe mental illness * Terminal illness

Contact & Investigator

Central Contact

Vivian Lou, PhD

✉ wlou@hku.hk

📞 +852 3917 4835

Frequently Asked Questions

Who can join the NCT06736782 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Long-Term Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06736782 currently recruiting?

Yes, NCT06736782 is actively recruiting participants. Contact the research team at wlou@hku.hk for enrollment information.

Where is the NCT06736782 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06736782 clinical trial?

NCT06736782 is sponsored by The University of Hong Kong. The trial plans to enroll 207 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology